Back to search
FDAFDA · Food and drugs·Recall number Z-2033-2024

Independent Medical Co-op Inc., Streptococcal A rapid test kits, labeled as: IMCO Strep A Rapid Test Strip and IMCO Strep A Rapid Test, Part Number STP25-IMC

Published June 19, 2024 · Recall initiated: April 22, 2024

Summary

FDA records medical device Class II recall Z-2033-2024, published June 19, 2024 and initiated April 22, 2024. Recalling firm: Wondfo USA Co Ltd; Status: Ongoing; Reported quantity: 102,500 units; Lot: Lot Numbers: W039301002, W039306002, W039312001, W03920403, W03920708, W03921003, W03921007. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Wondfo USA has identified unauthorized distribution of the Preview Strep A Test Kit. Unauthorized distribution of this device would include sales and distribution of this test for at-home use, non-prescription use, over-the-counter use, or direct-to-consumer customers.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Wondfo USA Co Ltd
Distributor
US Nationwide distribution.
Lot
Lot Numbers: W039301002, W039306002, W039312001, W03920403, W03920708, W03921003, W03921007
Risk classification
Class II
Area (FDA)
device
Country
United States

Related recalls

Questions about this recall

Was Independent Medical Co-op Inc., Streptococcal A rapid test kits, labeled as: IMCO Strep A Rapid Test Strip and IMCO Strep A Rapid Test, Part Number STP25-IMC recalled?

Yes. FDA published recall Z-2033-2024 on June 19, 2024. Reported hazard: Wondfo USA has identified unauthorized distribution of the Preview Strep A Test Kit. Unauthorized distribution of this device would include sales and distribution of this test for at-home use, non-prescription use, over-the-counter use, or direct-to-consumer customers.

What should I do if I have this product?

Voluntary: Firm initiated · Letter